|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/26 | (2006.01) |
| A61P 3/10 | (2006.01) |
| (11) | Patento numeris | 3244912 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16700758.2 |
| Europos patento paraiškos padavimo data | 2016-01-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-11-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-08-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2016/050804 |
| Data | 2016-01-15 |
| (87) | Numeris | WO 2016/113404 |
| Data | 2016-07-21 |
| (30) | Numeris | Data | Šalis |
| 15151488 | 2015-01-16 | EP |
| (72) |
BERGMANN, Karin , DE
HINCELIN-MÉRY, Agnès , FR
JAN, Christelle , FR
|
| (73) |
Sanofi-Aventis Deutschland GmbH ,
Brüningstraße 50, 65929 Frankfurt,
DE
|
| (54) | TREATMENT OF PEDIATRIC TYPE 2 DIABETES MELLITUS PATIENTS WITH LIXISENATIDE |
| TREATMENT OF PEDIATRIC TYPE 2 DIABETES MELLITUS PATIENTS WITH LIXISENATIDE |